Susan Duggan
Chief Operating Officer chez TRANSCODE THERAPEUTICS, INC.
Profil
Susan Duggan is currently the Senior Vice President-Operations at TransCode Therapeutics, Inc. She previously worked as the Director-Clinical Affairs at Medtronic Plc and as the Director-Clinical Operations at Samus Therapeutics, Inc. Ms. Duggan completed her undergraduate degree at Colby-Sawyer College and holds an MBA from Rivier University.
She also completed her undergraduate studies at Northern Essex Community College.
Postes actifs de Susan Duggan
Sociétés | Poste | Début |
---|---|---|
TRANSCODE THERAPEUTICS, INC. | Chief Operating Officer | - |
Anciens postes connus de Susan Duggan
Sociétés | Poste | Fin |
---|---|---|
MEDTRONIC PLC | Corporate Officer/Principal | - |
Samus Therapeutics, Inc.
Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Corporate Officer/Principal | - |
Formation de Susan Duggan
Colby-Sawyer College | Undergraduate Degree |
Rivier University | Masters Business Admin |
Northern Essex Community College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MEDTRONIC PLC | Health Technology |
TRANSCODE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Samus Therapeutics, Inc.
Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Health Technology |